New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Researchers have discovered that a drug originally developed for conditions like Alzheimer’s disease, schizophrenia, and ...
US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
The Healthy @Reader's Digest on MSN1d
New Study: Popular Weight Loss Drugs May Help Treat “the Most Widely Recognized” Hormone Issue Among WomenAround 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's ...
Eventually, Caroline dropped the drugs and focused on her diet. Her experience wasn’t unusual. When gastroenterologist Bruce Sands of the Icahn School of Medicine at Mount Sinai in New York City ...
Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors say they may also need to demonstrate ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...
Data on Lilly’s muscle mass-preserving drug, bimagrumab, is due this year. Westport, Connecticut-based New England Consulting Group estimates the drugs could collectively bring in $1 billion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results